Akorn, Inc. recalls Lidocaine Hydrochloride Jelly USP, 2%, Packaged as (a) 5 mL tube (NDC 17478-711-10) x10 per box NDC 17478-711-31; (b) 30
Recalled January 25, 2023 · FDA recall D-0143-2023 · Akorn
Hazard
CGMP Deviations: · FDA Class II
Units
2,369,258 tubes
Sold at
Nationwide in the USA
Description
CGMP Deviations:
Product
Lidocaine Hydrochloride Jelly USP, 2%, Packaged as (a) 5 mL tube (NDC 17478-711-10) x10 per box NDC 17478-711-31; (b) 30 mL tube NDC 17478-711-30; Rx only, Manufactured by: Akorn, Inc., Lake Forest, Il 60045.
Manufacturer(s)
Akorn, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →